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ABSTRACT
Objective: The objective of this study was to determine whether human papillomavirus (HPV)
infections are involved in the development ofpapillomatosis lesions ofthe lower female genital tract.
Methods: A total of 616 biopsy specimens of genital papillomatous lesions (307 nodular and 309
papular types) from 598 patients were anaylyzed for the presence of HPV DNA sequences by
polymerase chain reaction (PCR). These specimens were also examined by histopathological as-
sessment for characteristic HPV-associated cytological changes, by immunohistochemical staining
for HPV-associated antigen, and by electron microscopy for the presence of virions.
Results:HPVDNA sequences were found in 97.9% (140 of 143 cases) and 1.1% (1 of91 cases) of
the nodular and papular papillomatosis cases tested, respectively. In 18 patients who had both types
ofpapillomatosis lesions, HPVDNA was invariably found only in nodular tissues. HPV-associated
antigen, koilocytosis, and virions were found in 53.6% (98 of 183 cases), 70.5% (129 of 183 cases),
and 5.9% (5 of85 cases) of nodular papillomatosis lesions tested, respectively.
Conclusions: These data suggest that nodular papillomatosis was closely associated with HPV
infection, but that papular papillomatosis ofthe lower female genital tractmay have an etiology other
thanHPV infection. (C) 1994 Wiley-Liss, Inc.
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uman papillomaviruses (HPVs) are found fre-
quently in the female lower genital tract where
they induce different lesions depending on theHPV
types involved. The association between the pres-
ence of different types of I--IPV and clinical lesions
is better established for the cervix than for the
vulva. For example, vulvar vestibular papilloma-
tosis is one type of vulvar lesion whose origin and
clinical significance remain controversial. Fried-
rich
2 attributed the vestibular papillae present in
asymptomatic women as anatomic and/or functional
variants of normal vulvar epithelium. Pekham
et al.
3 and Friedrich
4 considered vestibular papil-
lomatosis a condition reactive to phylogosis caused
by non-viral agents. However, recent descriptions
of so-called "subclinical" HPV infections by Grow-
don et al.
5 and by Campion et al.
6 raised the ques-
tion of whether all these vestibular papillae were
indeed related to HPV infections.
7-1
Vulvar condyloma acuminatum, on the other
hand, is clearly caused by infection with certain
types ofHPV that are mainly transmitted through
sexual contact.
2-s Inquiries into the natural his-
tory and establishment of an unequivocal diagnosis
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ofHPV infection in vulvar vestibular papillomato-
sis have been hampered by the lack of an in vitro
propagation system for the virus and by the poor
correlation between HPV serology and disease ac-
tivity. In view of the rapid spreading of HPV
infection in recent years, both in Western coun-
tries7’12-18 and in China,
19,20 a reliable method for
the detection ofHPV infection and differential di-
agnosis between condyloma acuminata and vulvar
vestibular papillomatosis would help patient evalu-
ation and management.
In this paper, we report results of clinical and
laboratory examinations of papillomatosis lesions of
the lower female genital tract. The polymerase chain
reaction (PCR) technique, which was used to am-
plify HPV DNA sequences and to determine the
presence of HPV DNA sequences, was supple-
mented with histopathological assessments ofHPV
infections by immunohistochemical staining of
HPV-associated antigen, microscopy (both light




Between January 1990 and August 1992, a total of
616 vulvar papillomatosis biopsies (307 nodular
and 309 papular types) were obtained from 598
patients, including 18 patients who had both nodu-
lar and papular types of vulvar papillomatosis, be-
fore any therapeutic management was implemented.
The ages of these patients were between 14 and 48
years. Laboratory tests were performed and results
were analyzed in a double-blinded fashion.
Determination of HPV DNA Sequences
by PCR
Portions of freshly frozen tissues were treated with
proteinase K (Sigma Chemicals, St. Louis, MO).
DNA was extracted by phenol and chloroform and
purified by alcohol precipitation. Purified DNA
was then used as template for PCR amplification of
HPV DNA sequences. Consensus primers MY09
and MY ll commercially obtained from Perkin-
Elmer Cetus (Norwalk, CT) are capable of ampli-
fyingDNA from genital HPV types 6, 11, 16, 18,
31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55,
57, and 59 and from at least another 25 yet unchar-
acterized HPV types.
18 Dermal HPV types 1, 5,
8,26, 27, 41, 47, and 48 are also amplified with
TABLE I. Clinical and laboratory findings on nodular





(nodular type (papular type
lesions) lesions)
HP DNA (types 6, 97.9% I. I%
II, 16, 18, and 33) (140/143) (I/91)
HPV-associated 53.6% 0.9%
antigen (98/183) (2/225)
HPV virions 5.9% 0
(s/ss) (0/3)
History of multiple 80.8% 7. I%
sexual partners (248/307) (22/309)
*Results were presented as percentage of cases tested positive. Differ-
ences in all test items (exceptHP virions) between these two groups of
genital papillomatosis were statistically significant (P < 0.01 ).
these primers. Sequences of the oligonucleotide
primers were CGTCCMARRGAWACTGATC
and GCMCAGGWCATAAYAATGG (where
M=A+C, R=A+G, W=A+T, Y=
C + T). DNA samples, deoxyribonucleoside tri-
phosphates, and primers were heated in buffer to
95C for 5 min before TaqDNA polymerase (Per-
kin-Elmer Cetus) was added to the reaction mix-
ture and reaction started in a thermocycler (Model
480, Perkin-Elmer Cetus). The temperatures of
the reaction mixture were cycled 3 5 times through
95C denaturation (50 sec), 50C annealing (50
sec), and 72C extension (1 min) with a 5-min
incubation at 72C at the end. Positive and negative
control DNA were always included in every PCR
assay. Portions of the amplified reaction mixture
were separated by electrophoresis in 2% agarose gel
with pGEM-3 DNA digested with a mixture of
restriction endonucleases HinJI, RsaI, and SinI used
as size standards. The HPV positivity was deter-
mined by the presence of 450 base pairs of ampli-
fied HPVDNA on visual inspection under ultravi-
olet light after staining with ethidium bromide.
11
The types ofHPV were determined by hybridiza-
tion of amplified DNA with a radioactively labeled
type-specific internal oligonucleotide as probe. The
sensitivities of detection for HPV by our PCR
method were determined by amplifying either a
serial dilution of purified cloned HPV DNA of
known concentrations or DNA from CaSki and
HeLa cells.
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AtBIC
Fig. I. Gross features of nodular papillomatosis lesions in bunched grapes (A), flat warty (B), and
polyps (C) appearances.
Detection of HPV-Associated Antigen by
Avidin Biotin Complex (ABC) Immunochemical
Staining Method
ABC reagents were purchased from Vector Labora-
tories, Inc. (Burlingame, CA) and diluted 1:100
before use. Rabbit antisera directed againstL gene
product ofHPV (DAKO B580) and biotin-labeled
sheep anti-rabbit IgG antibodies were both diluted
1:200 before use. The presence of intranuclear
brownish-yellow granules after development with
diaminobenzidine (DAB) was considered an indi-
cation of HPV-associated antigen.
21
Microscopic Investigations
Light microscopic examinations of koilocytotic
changes of HPV-infected cells were performed af-
ter routine hematoxylin-eosin (H&E) staining.
12
Koilocytes are intermediate or mature squamous
cells characterized by a large perinuclear cavity.
Near the cavity, which has sharply defined bor-
ders, the cytoplasm is dense and often amphophilic.
Nuclei may be single or multiple. The nuclear
membrane is not apparent. In the fully developed
koilocyte, the chromatin is often smudged. These
cells often contain no nucleoli or inclusion bodies.
Electron microscopic studies ofHPV virions were
carried out with ultrathin sections of tissue slices
prepared by standard procedures and examined in a
JEM (Tokyo, Japan) 100CXII transmission elec-
tron microscope after being negatively stained with
phosphotungstic acid.
22
Clinical Management and Follow-Up
No treatment was given to those asymptomatic pa-
tients with papular papillomatosis. All patients were
examined every 2 weeks for at least 3 months.
RESULTS
The clinical and laboratory features and character-
istics of nodular and papular types of lesions of the
lower female genital tract were quite different. As
shown in Table 1, the differences in HPV preva-
lence, presence of HPV-associated antigen, koilo-
cytotic changes, and history of multiple sexual part-
ners between these two types of papillomatosis were
all statistically significant (P < 0.01).
Of the 307 women with nodular papillomatosis,
271 (88.3%) had multicentric involvement of the
lower genital tract (vagina, cervix, and perineum),
25 (8.1%) had lesions confined to the cervix, and
11 (3.6%) had lesions confined to the vagina. Gross
appearances of these nodular papillomatosis cases
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Fig. 2. Clinical features of papular papillomatosis. A: Teardrop pattern; I: finger-like papillae
usually 5-8 mm in. length; and C: patterned vascular architectures under colposcope.
consisted of those shaped like polyps, chicken-
crowns, or bunched grapes found in lower genital
tract and perineum areas (272 cases); fuzzy-ball
appearances found in the vestibular area (8 cases),
and flat warty appearances found in the cervix (20
cases) (Fig. 1). The gross appearances of the 309
cases of papular papillomatosis were mostly soft and
smooth teardrops or roughened and raised mucosal
surfaces (Fig. 2A) or finger-like (Fig. 2B) projec-
tions with patterned vascular architectures on col-
poscopy (Fig. 2C). Among 309 cases of the papu-
lar lesions, 279 (90.3%) were found on the inside
mucosal surface of the labia minora and 30 (9.7%)
were found in the vagina.
HPV DNA sequences of one or more types of
HPV could be detected in 140 of" 143 (97.9%)
cases of nodular papillomatosis lesions tested by the
PCR method (Fig. 3). Repeated testing of the 3
HPV negative cases was not possible because no
papillomatosis tissue was left after the first biopsy.
On the other hand, only of the 91 (1.1%) papular
papillomatosis tissue tested positive for HPV DNA
with the PCR method, and this single case became
negative when tested again a week later. Four of the
HPVDNA negative cases were tested negative 2 or
3 times upon patients’ requests within a 6-month
period. Noteworthy were the HPV DNA PCR test
results on specimens obtained from 18 patients who
were found to have both nodular and papular types
of papillomatosis on the mucosal surface of their
labia minora or lower vagina. HPV DNA se-
quences were found in all 18 nodular portions but
in none of the papular portions of the lesions. Two
women with sparse and very minute lesions of un-
certain classification who tested positive for HPV
DNA sequences had developed nodular lesions
when examined again 2 weeks later.
HPV-associated antigen could be stained by the
immunohistochemical method in 98 of 183 cases
(53.6%) of nodular lesions tested but in only 2 of
225 cases (0.9%) of papular type of papillomatosis
lesion examined with the same method (Fig. 4). No
characteristic koilocytotic changes were seen in the
papular papillomatosis tissues. Other microstruc-
tural features in the cells of the nodular papilloma-
tosis included the disappearance of cellular or-
ganelles, enlargement of mitochondria, and vacuole
formation in the nuclei. Electron microscopy re-
238 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYVULVAR HPV INFECTIONS FU ET AL.
1 2 3 4 5 6 7 8 9
Fig. 3. Agarose gel electrophoresis of amplified HPV DNA
using consensus primers and under conditions described in
"Subjects and Methods." pGEM-3 DNA digested with a mix-
ture of restriction endonucleases Hinfl, Rsal, and Sinl was
used as size standards in the 2 outside lanes, and the sizes are
(from top to bottom) 2,645, 1,605, 1,198, 676, 517, 460,
396; 350, 222, 179, 126, 75, 65, 51, and 36 base pairs. Lanes
I,:2= Amplification ofDNA from purified cloned HPV types 6
and DNA, respectively. Lanes :3,4: Amplification of nod-
ular and papular papillomatosis tissues from 2 patients, re-
spectively. Lanes 5,6: Amplification of DNA from nodular
and papular portions of papillomatosis tissues of a single
patient, respectively. Lane 7: Amplification of 50 ng of hu-
man DNA with the HPV consensus primers MY09 and MY I.
Lanes 8,9: Amplification of CaSki and HeLa cells, respec-
tively, which are known to contain HPV types 16 and 18,
respectively.
vealed a grid pattern and round HPV virion-like
structure of 40-50 Ixm in diameter in 5 of 85 cases
(5.9%) of nodular papillomatosis lesions examined
(Fig. 5). No such virion-like structure could be
found in 23 papular papillomatosis tissues.
All 7 cases of papular papillomatosis from pa-
tients who were pregnant regressed spontaneously
within 1-42 days (mean 14 days) after pregnancies
were terminated by abortion or induced or term
delivery, but none of the 8 cases of pregnant women
with nodular papillomatosis regressed spontaneously
during the same period after termination of preg-
nancy. None of the 89 patients with asymptomatic
and untreated papular papillomatosis developed
nodular papillomatosis during follow-up of 3
months to 2 years (mean 4 months). No case of
genital warts could be documented among sexual
partners of patients with papular papillomatosis. A
history of multiple sexual partners was admitted by
248 of 307 (80.8%) patients with nodular papillo-
rnatosis, but by only 22 of 309 (7.1%) patients with
papular papillomatosis. Furthermore, 23 of 309
patients with papular papillomatosis were young
virginal women in their 20s with intact hymen
upon physical examinations.
DISCUSSION
Research in the pathogenesis ofHPV in the past has
concentrated on the carcinogenic nature of HPV
and on the development of condyloma acumina-
tum. Relatively little is known so far on whether
HPV infection is really involved in the develop-
ment of vestibular papillae or papular papillomato-
sis of the lower female genital tract. The term
"pseudocondyloma" based on HPV-associated anti-
gen studies and the term "condyloma-like vulvar
lesions" based on pathophysiological studies on
koilocytotic cells have been used synonymously to
describe these lesions.
10 Various other terminolo-
gies have also been found in the literature to de-
scribe these papular papillomatosis lesions which
include "subclinical HPV infections," "precondy-
loma," and condyloma,
v-9 There is no consensus on
the possible origin and etiology of these lesions,
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 239VULVAR HPV INFECTIONS FU ET AL.
Fig. 4. Immunohistochemical staining of HPV L gene antigen byABC method. Presence of HPV L
gene antigen is indicated by granules inside nuclei that stained brownish-yellow with DAB.
Fig. 5. HPV virions under electron microscope. 330,410.
although it has been reported that patients with
vulvar micropapillomatosis are not significantly
more frequently infected with HPV than controls.
23
The PCR method used in this study has a lower
limit of detection of approximately 50-500 viral
genomes equivalent (based on HPV types 6, 11,
16, and 18 results) depending on the type of I-IPV.
Our PCR results indicated that the HPVs present
in almost all nodular lesions but were either present
in extremely small quantity (estimated to be less
than copy per 3,000 cells) or, more likely, not
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present in papular lesions at all. Because of its
technically demanding and labor-intensive nature,
electron microscopy has probably only very limited
use in the diagnosis ofHPV infections.
In summary, HPVDNA sequences, I-IPV-asso-
ciated antigen, koilocytotic changes, and virions
can be found very frequently in nodular papilloma-
tosis lesions of the lower female genital tract. These
lesions can be transmitted efficiently by sexual con-
tact. On the other hand, our results also clearly
suggest that papular papillomatosis lesions very
rarely contain HPV DNA sequences. We believe
that these HPV DNA results, when taken together
with other laboratory tests carried out in this study,
suggest that prudence should be exercised in inter-
preting the nature and origin of papular papilloma-
tosis lesions, especially in asymptomatic women
without other clinical indications.
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